# Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY

> **NCT00235222** · PHASE4 · UNKNOWN · sponsor: **Groupe Hospitalier Pitie-Salpetriere** · enrollment: 57 (—)

## Conditions studied

- HIV

## Interventions

- **DRUG:** stavudine

## Key facts

- **NCT ID:** NCT00235222
- **Lead sponsor:** Groupe Hospitalier Pitie-Salpetriere
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 57 (—)
- **Last updated:** 2005-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235222, "Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00235222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*